Tekmira +9% as Maxim boosts PT

"When we first launched coverage of Tekmira (TKMR +8.9%) on June 18, 2013 at $4.80 we modeled our expectations with a high degree of conservatism using a 30% risk rate across the complete model," says analyst Jason Kolbert. "We are now lowering that discount rate from 30% to 15%."

The new price target of $31 is up from $17 previously.

The lower discount rate is thanks to progress of Tekmira partners Alnylam (ALNY -1.1%), Marqibo, and Monsanto, and the ever-rising evidence of the viability of SiRNA and the platform required to deliver it. He notes the gains in Isis Pharma last week amid preliminary test data, and the continued rise in Alnylam since Sanofi agreed to pay $700M for access to rare-disease treatments, and took a 12% stake in the company.

From other sites
Comments (3)
  • SimonSaysShort
    , contributor
    Comments (116) | Send Message
    Ohh, and the raised PT has nothing to do with being a part of last week's capital raise? Sure...
    24 Feb 2014, 12:10 PM Reply Like
  • GrowthGeek
    , contributor
    Comments (2774) | Send Message
    Look at BNIKF if you want to find a relatively undiscovered stock in this same sector ddRNAi to be specific with incredible potential. It has been rocketing up recently.
    24 Feb 2014, 01:15 PM Reply Like
  • ShortSlaver
    , contributor
    Comments (82) | Send Message
    Still a very conservative estimate. So many positive catalysts over the next year I would expect to see tkmr get into the 60-70 range EOY and have a target at 100 for 2015. A nice raise at 30 would ensure more targets and feed large buyins across the industry. It's rocket sheep time - just getting started.
    24 Feb 2014, 08:45 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs